Medical Device Bio-engineered Stent Market Trends And Growth | Page 2

REPORT DESCRIPTION
Bio-engineered Stent Market – Overview
Bio-engineered stent plays a major role in modern healthcare as it expands the blood vessel to prevent a
blockage of arteries in cardiovascular diseases such as coronary heart disease and ischemic heart disease.
The global bio-engineered stent market size was valued at US$ 2,764.2 million in 2017, and is projected to
exhibit a CAGR of 8.7% over the forecast period (2018 – 2026).
Bio-engineered stent is used in treating blockage of coronary and peripheral artery, which is related to
coronary heart disease, ischemic heart disease, and other cardiovascular diseases. High prevalence of
coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to propel
demand for bio-engineered stent, which in turn is expected to drive the market growth. According to
American Heart Association, in 2018, around 92.1 million people in the U.S. were suffering with some
form of cardiovascular diseases or the after-effects of stroke. Moreover, around 836,546 deaths in the U.S.
were due to cardiovascular diseases, which accounted for 1 in every 3 deaths in the country. Direct and
indirect costs in the treatment of cardiovascular diseases and stroke in the country were estimated to be
around US$ 329.7 billion in 2018, which includes both health expenditures and lost productivity.